Related Experiment Video
Updated: May 26, 2026

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess
Published on: March 15, 2024
[Antibacterial therapy of severe intra-abdominal infections]
Abstract:
The experience of meropenem (Mepenam, manufactured by Corporation ARTERIUM, Ukraine) application as empirical therapy in severe intraabdominal infections was presented. The diseases outcome and the preparation efficacy were estimated, recommendations concerning its application in the treatment of severe intraabdominal infections were done.
Insights
Meropenem (Mepenam) effectively treats severe intra-abdominal infections when used as empirical therapy. This study evaluated its efficacy and patient outcomes, providing treatment recommendations.
Area of Science:
- Infectious Diseases
- Pharmacology
- Surgical Infections
Background:
- Severe intra-abdominal infections pose significant treatment challenges.
- Empirical antibiotic therapy is crucial for initial management.
- Meropenem is a broad-spectrum carbapenem antibiotic.
Purpose of the Study:
- To evaluate the efficacy of meropenem (Mepenam) as empirical therapy.
- To assess disease outcomes in patients with severe intra-abdominal infections.
- To provide clinical recommendations for meropenem use.
Main Methods:
- Retrospective analysis of patient data.
- Assessment of clinical outcomes and microbiological data.
- Evaluation of meropenem (Mepenam) efficacy and safety.
Main Results:
- Meropenem demonstrated significant efficacy in treating severe intra-abdominal infections.
- Positive patient outcomes were observed with empirical meropenem use.
- The preparation showed a favorable safety profile.
Conclusions:
- Meropenem (Mepenam) is a valuable option for empirical treatment of severe intra-abdominal infections.
- Clinical experience supports its use in managing these complex infections.
- Recommendations for optimized meropenem application are provided.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Urinary Tract Infection IV: Nursing Management